Pancreatic lesions are too often missed

EUS has changed what’s possible in pancreatic lesion detection, but its complexity often results in doubt and variation in finding lesions. Not seeing a lesion after suspicious prior tests can create concern that something critical has been overlooked, affecting outcomes and confidence across teams.

Small lesions are often missed

Early-stage pancreatic lesions are easy to miss, resulting in fewer treatment options later on, leading to dramatically worse outcomes.

EUS requires years of training

Staying oriented, navigating the pancreas, and covering every region thoroughly takes years of training. Even seasoned experts can leave with doubt about whether they missed a lesion, while juniors need longer supervision.

Outcomes are inconsistent

Variation between clinicians and across departments creates uncertainty for patients and reputational risk for hospitals striving to deliver excellence every time.

mAI Companion®: A trusted AI companion for pancreatic EUS

mAI Companion® was created to support endoscopists where it matters most: ensuring systematic coverage and detection of pancreatic lesions through 2 dedicated AI Models.

① Anatomical orientation guides the comprehensive coverage of the pancreatic regions.

② Lesion detection acts as a second set of eyes to identify smaller tissue abnormalities.

Not ready to book a demo yet?

Get answers to the questions that matter most.

We’ve created a short video guide that addresses the most common concerns from department heads and senior endoscopists when considering AI in EUS.

From how the system fits into existing workflows, to what makes its performance reliable, you’ll get clear, practical answers that help you evaluate if mAI Companion® is right for your team.